Atlas Trials

18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy

Clinical trial NCT07724535 · RECRUITING

Trial details

NCT number
NCT07724535
Sponsor
Peking University Cancer Hospital & Institute
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2026-06-24
Primary completion
2028-07-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.